Respiratory Illness
- United States
Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-19
Charlotte, N.C., United States: Topline clinical trial results showed LEUKINE® was safe, well tolerated and generated T cells targeted at…
Read More » - Health
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19
Ingelheim, Germany: Trial will evaluate BI 764198, a novel first-in-class compound, for hospitalized people infected with SARS-CoV-2 with severe respiratory…
Read More »